Acesion Pharma Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met

Acesion Pharma Positive phase 2 data from Atrial Fibrillation clinical trial – primary endpoint met

Mar 14, 2023

 

 

 

Link to full press release